Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Diagnostic Performance of In-Procedure Angiography-Derived Quantitative Flow Reserve Compared to Pressure-Derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study.

Westra J, Andersen BK, Campo G, Matsuo H, Koltowski L, Eftekhari A, Liu T, Di Serafino L, Di Girolamo D, Escaned J, Nef H, Naber C, Barbierato M, Tu S, Neghabat O, Madsen M, Tebaldi M, Tanigaki T, Kochman J, Somi S, Esposito G, Mercone G, Mejia-Renteria H, Ronco F, Bøtker HE, Wijns W, Christiansen EH, Holm NR.

J Am Heart Assoc. 2018 Jul 6;7(14). pii: e009603. doi: 10.1161/JAHA.118.009603.

2.

Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Sommer T, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Jun 12. doi: 10.1002/clc.22996. [Epub ahead of print]

3.

Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.

Liebetrau C, Gaede L, Kim WK, Arsalan M, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Kriechbaum S, Huber MT, van Linden A, Berkowitsch A, Dörr O, Nef H, Hamm CW, Walther T, Möllmann H.

Int J Cardiol. 2018 Aug 15;265:40-46. doi: 10.1016/j.ijcard.2018.02.037.

PMID:
29885699
4.

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.

Eur Heart J. 2018 Jun 7;39(22):2032-2046. doi: 10.1093/eurheartj/ehy076.

5.

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.

Eur Heart J. 2018 Jun 7;39(22):2047-2062. doi: 10.1093/eurheartj/ehy077.

6.

Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Tabert H, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Apr;41(4):481-487. doi: 10.1002/clc.22900. Epub 2018 Apr 17.

7.

Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy.

Wöhrle J, Nef HM, Naber C, Achenbach S, Riemer T, Mehilli J, Münzel T, Schneider S, Markovic S, Seeger J, Rottbauer W, Pfannebecker T, Richardt G, Zahn R, Gori T, Kastner J, Schmermund A, Hamm CW; GABI-R Study Group.

Coron Artery Dis. 2018 Aug;29(5):389-396. doi: 10.1097/MCA.0000000000000618.

PMID:
29649071
8.

Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry Results.

Ellis SG, Gori T, Serruys PW, Nef H, Steffenino G, Brugaletta S, Munzel T, Feliz C, Schmidt G, Sabaté M, Onuma Y, van Geuns RJ, Gao RL, Menichelli M, Kereiakes DJ, Stone GW, Testa L, Kimura T, Abizaid A.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):638-644. doi: 10.1016/j.jcin.2017.11.042.

PMID:
29622141
9.

A multicenter post-marketing evaluation of the Elixir DESolve® Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study.

Nef H, Wiebe J, Boeder N, Dörr O, Bauer T, Hauptmann KE, Latib A, Colombo A, Fischer D, Rudolph T, Foin N, Richardt G, Hamm C.

Catheter Cardiovasc Interv. 2018 Mar 6. doi: 10.1002/ccd.27550. [Epub ahead of print]

PMID:
29508518
10.

Outcome of thrombus aspiration in STEMI patients: a propensity score-adjusted study.

Blumenstein J, Kriechbaum SD, Leick J, Meyer A, Kim WK, Wolter JS, Abu-Samra M, Weipert K, Bayer M, Dörr O, Walther C, Hamm CW, Nef H, Liebetrau C, Möllmann H.

J Thromb Thrombolysis. 2018 Feb;45(2):240-249. doi: 10.1007/s11239-017-1601-2.

PMID:
29274046
11.

Outcome after transvascular transcatheter aortic valve implantation in 2016.

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Husser O, Elsässer A, Hamm CW, Möllmann H.

Eur Heart J. 2018 Feb 21;39(8):667-675. doi: 10.1093/eurheartj/ehx688.

12.

Restenosis patterns after bioresorbable vascular scaffold implantation: Angiographic substudy of the GHOST-EU registry.

Baquet M, Nef H, Gori T, Latib A, Capodanno D, Di Mario C, Sabate M, Colombo A, Tamburino C, Mehilli J.

Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27350. [Epub ahead of print]

PMID:
29171715
13.

Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry.

Möllmann H, Hengstenberg C, Hilker M, Kerber S, Schäfer U, Rudolph T, Linke A, Franz N, Kuntze T, Nef H, Kappert U, Walther T, Zembala MO, Toggweiler S, Kim WK.

EuroIntervention. 2018 Feb 2;13(15):e1764-e1770. doi: 10.4244/EIJ-D-17-00628.

14.

Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.

Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, Adriaenssens T, Loh JP, Lattuca B, Wykrzykowska JJ, Gomez-Lara J, Timmers L, Motreff P, Hoppmann P, Abdel-Wahab M, Byrne RA, Meincke F, Boeder N, Honton B, O'Sullivan CJ, Ielasi A, Delarche N, Christ G, Lee JKT, Lee M, Amabile N, Karagiannis A, Windecker S, Räber L.

J Am Coll Cardiol. 2017 Nov 7;70(19):2330-2344. doi: 10.1016/j.jacc.2017.09.014.

PMID:
29096803
15.

Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.

Capranzano P, Capodanno D, Brugaletta S, Latib A, Mehilli J, Nef H, Gori T, Lesiak M, Geraci S, Pyxaras S, Mattesini A, Münzel T, Araszkiewicz A, Caramanno G, Naber C, Di Mario C, Sabatè M, Colombo A, Wiebe J, Tamburino C.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):444-453. doi: 10.1002/ccd.27388. Epub 2017 Oct 25.

PMID:
29068130
16.

[Heart valve disesases : How sufficient is the knowledge of the German population?]

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Hamm C, Elsässer A, Nef H, Möllmann H.

Herz. 2017 Oct 20. doi: 10.1007/s00059-017-4632-8. [Epub ahead of print] German.

PMID:
29052748
17.

Pacemaker implantation after TAVI: predictors of AV block persistence.

Gaede L, Kim WK, Liebetrau C, Dörr O, Sperzel J, Blumenstein J, Berkowitsch A, Walther T, Hamm C, Elsässer A, Nef H, Möllmann H.

Clin Res Cardiol. 2018 Jan;107(1):60-69. doi: 10.1007/s00392-017-1158-2. Epub 2017 Sep 29.

PMID:
28963581
18.

Coronary Artery Aneurysm With Thrombosis After Implantation of a Bioresorbable Coronary Artery Scaffold.

Hemetsberger R, Gürocak O, Soud M, Garcia-Garcia HM, Weber-Albers J, Nef H, Möllmann H.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):e173-e174. doi: 10.1016/j.jcin.2017.07.041. No abstract available.

PMID:
28935086
19.

Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis.

Ellis SG, Steffenino G, Kereiakes DJ, Stone GW, van Geuns RJ, Abizaid A, Nef H, Cortese B, Testa L, Menichelli M, Tamburino C, Gori T, Kimura T, Serruys PW, Brugaletta S, Sabaté M, Gao RL.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1809-1815. doi: 10.1016/j.jcin.2017.06.067.

PMID:
28935071
20.

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R).

Nef HM, Wiebe J, Kastner J, Mehilli J, Muenzel T, Naber C, Neumann T, Richardt G, Schmermund A, Woehrle J, Zahn R, Riemer T, Achenbach S, Hamm CW.

EuroIntervention. 2017 Dec 20;13(11):1311-1318. doi: 10.4244/EIJ-D-17-00330.

21.

Identification of Periprocedural Myocardial Infarction Using a High-Sensitivity Troponin I Assay in Patients Who Underwent Transcatheter Aortic Valve Implantation.

Liebetrau C, Kim WK, Meyer A, Arsalan M, Gaede L, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Dörr O, Schillinger S, Troidl C, Nef HM, Hamm CW, Walther T, Möllmann H.

Am J Cardiol. 2017 Oct 1;120(7):1180-1186. doi: 10.1016/j.amjcard.2017.06.069. Epub 2017 Jul 14.

PMID:
28826900
22.

Applicability and procedural success rate of bioresorbable -vascular scaffolds for percutaneous coronary intervention in an all-comer cohort of 383 consecutive patients.

Schlundt C, Achenbach S, Felten F, Roether J, Marwan M, Nef H, Ludwig J, Tröbs M.

Acta Cardiol. 2017 Aug;72(4):425-432. doi: 10.1080/00015385.2017.1307659. Epub 2017 Jul 14.

PMID:
28705057
23.

Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.

Gaede L, Liebetrau C, Dörr O, Blumenstein J, Elsässer A, Hamm CW, Möllmann H, Schlundt C, Nef HM, Achenbach S.

Coron Artery Dis. 2017 Nov;28(7):588-596. doi: 10.1097/MCA.0000000000000533.

PMID:
28704242
24.

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R.

Mehilli J, Achenbach S, Woehrle J, Baquet M, Riemer T, Muenzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C.

EuroIntervention. 2017 Dec 20;13(11):1319-1326. doi: 10.4244/EIJ-D-17-00291.

25.

Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.

Boeder NF, Dörr O, Bauer T, Mattesini A, Elsässer A, Liebetrau C, Achenbach S, Hamm CW, Nef HM.

Int J Cardiol. 2017 Nov 1;246:74-79. doi: 10.1016/j.ijcard.2017.05.087. Epub 2017 May 24.

PMID:
28579164
26.

Myocardial Ischemia Caused by Subepicardial Hematoma.

Grieshaber P, Nef H, Böning A, Niemann B.

Thorac Cardiovasc Surg Rep. 2017 Jan;6(1):e5-e9. doi: 10.1055/s-0037-1601315.

27.

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry.

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabate M, Tamburino C, Nef H, Gori T.

EuroIntervention. 2017 Oct 13;13(9):e1104-e1111. doi: 10.4244/EIJ-D-16-00568.

28.

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.

Geraci S, Kawamoto H, Caramanno G, Ruparelia N, Capodanno D, Brugaletta S, Gori T, Nef H, Sabate M, Mehilli J, Lesiak M, Naber C, Di Mario C, Capranzano P, Wiebe J, Araszkiewicz A, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Colombo A, Latib A.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):560-568. doi: 10.1016/j.jcin.2016.12.013. Epub 2017 Mar 1.

29.

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

EuroIntervention. 2017 Apr 20;12(17):2110-2117. doi: 10.4244/EIJ-D-16-00974.

PMID:
28246060
30.

Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison.

Wiebe J, Dörr O, Ilstad H, Husser O, Liebetrau C, Boeder N, Bauer T, Möllmann H, Kastrati A, Hamm CW, Nef HM.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):477-485. doi: 10.1016/j.jcin.2016.11.034. Epub 2017 Feb 15.

31.

Outcome After Long-segment Stenting With Everolimus-eluting Bioresorbable Scaffolds Focusing on the Concept of Overlapping Implantation.

Wiebe J, Dörr O, Liebetrau C, Bauer T, Wilkens E, Ilstad H, Boeder N, Elsässer A, Möllmann H, Hamm CW, Nef HM.

Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1144-1151. doi: 10.1016/j.rec.2016.08.012. Epub 2016 Oct 27. English, Spanish.

PMID:
28134094
32.

Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair.

Gaede L, Blumenstein J, Kim WK, Liebetrau C, Dörr O, Nef H, Hamm C, Elsässer A, Möllmann H.

Clin Res Cardiol. 2017 Jun;106(6):411-419. doi: 10.1007/s00392-016-1070-1. Epub 2017 Jan 11.

PMID:
28078447
33.

Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.

Blachutzik F, Boeder N, Wiebe J, Mattesini A, Dörr O, Most A, Bauer T, Tröbs M, Röther J, Schlundt C, Achenbach S, Hamm C, Nef H.

Heart Vessels. 2017 Jul;32(7):781-789. doi: 10.1007/s00380-016-0932-9. Epub 2016 Dec 21.

PMID:
28004176
34.

Bioresorbable scaffold implantation in patients with indication for oral anticoagulation: A propensity matched analysis.

Boeder NF, Johnson V, Dörr O, Wiebe J, Elsässer A, Möllmann H, Hamm CW, Nef HM, Bauer T.

Int J Cardiol. 2017 Mar 15;231:73-77. doi: 10.1016/j.ijcard.2016.11.280. Epub 2016 Nov 24.

PMID:
27899203
35.

Endocarditis after interventional repair of the mitral valve: Review of a dilemma.

Boeder NF, Dörr O, Rixe J, Weipert K, Bauer T, Bayer M, Hamm CW, Nef HM.

Cardiovasc Revasc Med. 2017 Mar;18(2):141-144. doi: 10.1016/j.carrev.2016.11.003. Epub 2016 Nov 10. Review.

PMID:
27890554
36.

A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives.

Nef HM, Wiebe J, Foin N, Blachutzik F, Dörr O, Toyloy S, Hamm CW.

Int J Cardiol. 2017 Jan 15;227:127-133. doi: 10.1016/j.ijcard.2016.11.033. Epub 2016 Nov 9. Review.

PMID:
27863289
37.

Optical coherence tomography: influence of contrast concentration on image quality and diagnostic confidence.

Blachutzik F, Achenbach S, Nef H, Hamm C, Dörr O, Boeder N, Marwan M, Tröbs M, Schneider R, Röther J, Schlundt C.

Heart Vessels. 2017 Jun;32(6):653-659. doi: 10.1007/s00380-016-0918-7. Epub 2016 Nov 9.

PMID:
27830336
38.

Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction.

Liebetrau C, Gaede L, Wolter JS, Homann J, Meyer A, Dörr O, Nef HM, Troidl C, Hamm CW, Möllmann H, Richards AM, Pemberton CJ.

Biomarkers. 2017 May - Jun;22(3-4):304-310. doi: 10.1080/1354750X.2016.1252965. Epub 2016 Nov 22.

PMID:
27775442
39.

[Bifurcation lesions : How should they be assessed and treated?]

Nef HM, Dörr O, Möllmann H, Elsässer A.

Herz. 2016 Nov;41(7):572-578. Review. German.

PMID:
27717991
40.

Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.

Blachutzik F, Boeder N, Wiebe J, Mattesini A, Dörr O, Most A, Bauer T, Röther J, Tröbs M, Schlundt C, Achenbach S, Hamm CW, Nef HM.

Clin Res Cardiol. 2017 Apr;106(4):271-279. doi: 10.1007/s00392-016-1048-z. Epub 2016 Oct 18.

PMID:
27757522
41.

Thebesian veins as drainage to the ventricle: A case report.

F Boeder N, Nef HM, Bauer T.

Cardiovasc Revasc Med. 2017 Apr - May;18(3):213-214. doi: 10.1016/j.carrev.2016.09.007. Epub 2016 Sep 30.

PMID:
27743821
42.

Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) prospective study. Rationale and design.

Kennedy MW, Fabris E, Ijsselmuiden AJ, Nef H, Reith S, Escaned J, Alfonso F, van Royen N, Wojakowski W, Witkowski A, Indolfi C, Ottervanger JP, Suryapranata H, Kedhi E.

Cardiovasc Diabetol. 2016 Oct 10;15(1):144.

43.

Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study.

Tu S, Westra J, Yang J, von Birgelen C, Ferrara A, Pellicano M, Nef H, Tebaldi M, Murasato Y, Lansky A, Barbato E, van der Heijden LC, Reiber JH, Holm NR, Wijns W; FAVOR Pilot Trial Study Group.

JACC Cardiovasc Interv. 2016 Oct 10;9(19):2024-2035. doi: 10.1016/j.jcin.2016.07.013.

44.

Anatomical and procedural determinants of catheter-based renal denervation.

Ewen S, Ukena C, Lüscher TF, Bergmann M, Blankestijn PJ, Blessing E, Cremers B, Dörr O, Hering D, Kaiser L, Nef H, Noory E, Schlaich M, Sharif F, Sudano I, Vogel B, Voskuil M, Zeller T, Tzafriri AR, Edelman ER, Lauder L, Scheller B, Böhm M, Mahfoud F.

Cardiovasc Revasc Med. 2016 Oct - Nov;17(7):474-479. doi: 10.1016/j.carrev.2016.08.004. Epub 2016 Aug 20.

PMID:
27617388
45.

N-terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro.

Lipps C, Nguyen JH, Pyttel L, Lynch TL 4th, Liebetrau C, Aleshcheva G, Voss S, Dörr O, Nef HM, Möllmann H, Hamm CW, Sadayappan S, Troidl C.

J Mol Cell Cardiol. 2016 Oct;99:47-56. doi: 10.1016/j.yjmcc.2016.09.003. Epub 2016 Sep 8.

46.

Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery disease.

Cook S, Nef H, Capodanno D, Tamburino C, Baumbach A.

EuroIntervention. 2016 Aug 20;12(6):801-4. doi: 10.4244/EIJV12I6A130. No abstract available.

47.

Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.

Ortega-Paz L, Capodanno D, Giacchi G, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

Catheter Cardiovasc Interv. 2017 Apr;89(5):812-818. doi: 10.1002/ccd.26674. Epub 2016 Aug 12.

PMID:
27515568
48.

Absorb vs. DESolve: an optical coherence tomography comparison of acute mechanical performances.

Mattesini A, Boeder N, Valente S, Löblich K, Dörr O, Secco GG, Foin N, Caiazzo G, Ghione M, Gensini GF, Porto I, Di Mario C, Nef H.

EuroIntervention. 2016 Aug 5;12(5):e566-73. doi: 10.4244/EIJV12I5A96.

49.

Temporal trends in transcatheter and surgical aortic valve replacement : An analysis of aortic valve replacements in Germany during 2012-2014.

Gaede L, Kim WK, Blumenstein J, Liebetrau C, Dörr O, Nef H, Hamm C, Walther T, Achenbach S, Elsässer A, Möllmann H.

Herz. 2017 May;42(3):316-324. doi: 10.1007/s00059-016-4461-1. Epub 2016 Aug 5.

PMID:
27491767
50.

Effects of renal denervation on heart failure biomarkers and blood pressure in patients with resistant hypertension.

Neumann JT, Ewen S, Mortensen K, Nef H, Zeller T, Ojeda F, Sydow K, Mahfoud F, Böhm M, Hamm C, Dörr O, Blankenberg S.

Biomark Med. 2016 Aug;10(8):841-51. doi: 10.2217/bmm-2016-0098.

PMID:
27428075

Supplemental Content

Support Center